Literature DB >> 11903341

Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis.

S D Avakian1, J M Annicchino-Bizzacchi, M Grinberg, J A Ramires, A P Mansura.   

Abstract

Hypercholesterolemia has been related to aortic valve stenosis (AS). Polymorphisms of apolipoproteins (apo) AI, B, and E are associated with variable levels of plasma lipids, but the association between these polymorphisms and AS is unknown. In a case-control study of groups matched by age, sex, comparable body mass index, hypertension, triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol, we analyzed the distribution of apo AI A/G mutation, apo B signal peptide insertion/deletion, apo B XbaI restriction fragment length. and apo E polymorphisms in 62 non-diabetic patients with severe aortic valve stenosis and 62 control subjects. All patients underwent echocardiographic analysis. Univariate analysis showed a higher prevalence of the XbaI X + /X + genotype (p = 0.007) of apo B and the apo E2 allele (p = 0.034) in patients with severe AS. Apo polymorphisms were not associated with lipid levels, left ventricular mass, or the aortic gradient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903341     DOI: 10.1034/j.1399-0004.2001.600511.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 2.  Genetic predisposition to calcific aortic stenosis and mitral annular calcification.

Authors:  Anton G Kutikhin; Arseniy E Yuzhalin; Elena B Brusina; Anastasia V Ponasenko; Alexey S Golovkin; Olga L Barbarash
Journal:  Mol Biol Rep       Date:  2014-06-06       Impact factor: 2.316

Review 3.  Reassessment of statins to retard the progression of aortic stenosis.

Authors:  Nalini M Rajamannan
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

4.  APOE alleles are not associated with calcific aortic stenosis.

Authors:  J R Ortlepp; M Pillich; V Mevissen; C Krantz; M Kimmel; R Autschbach; G Langebartels; J Erdmann; R Hoffmann; K Zerres
Journal:  Heart       Date:  2006-04-10       Impact factor: 5.994

Review 5.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

Review 6.  Calcific aortic stenosis: lessons learned from experimental and clinical studies.

Authors:  Nalini M Rajamannan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-20       Impact factor: 8.311

7.  Analysis of Serum Metabolites to Diagnose Bicuspid Aortic Valve.

Authors:  Wenshuo Wang; Aikebaier Maimaiti; Yun Zhao; Lingfei Zhang; Hongyue Tao; Hui Nian; Limin Xia; Biao Kong; Chunsheng Wang; Mofang Liu; Lai Wei
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

8.  Associations of the APOB rs693 and rs17240441 polymorphisms with plasma APOB and lipid levels: a meta-analysis.

Authors:  Caiqin Niu; Zhi Luo; Liuqin Yu; Yang Yang; Yun Chen; Xin Luo; Feiya Lai; Yongyan Song
Journal:  Lipids Health Dis       Date:  2017-09-06       Impact factor: 3.876

9.  Association between apolipoprotein B genetic polymorphism and the risk of calcific aortic stenosis in Chinese subjects, in Xinjiang, China.

Authors:  Yong-Tao Wang; Yang Li; Yi-Tong Ma; Yi-Ning Yang; Xiang Ma; Xiao-Mei Li; Fen Liu; Bang-Dang Chen
Journal:  Lipids Health Dis       Date:  2018-03-07       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.